GlaxoSmithKline Realignes Regions, Changes Executive Team

In the office.
And on the beach

The web magazine for top managers - who's promoted, who came, who left? And what to do when you're not in the office.

April 30, 2008, London, UK - GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, announced a number of changes to its Corporate Executive management team.

In a message to employees, Andrew Witty, CEO designate, detailed new appointments and his new management team which will take effect on May 22nd when he assumes the role of Chief Executive Officer.

"Emerging markets, such as Brazil, Russia, India, China and the Middle East, are already contributing close to 25% of today's market growth and are forecast to grow even faster in the future. I am therefore creating a new Emerging Markets region", said Mr. Witty. A new Asia Pacific region will also be created, which includes Japan and Australia. As part of the changes to business regions, GSK has also realigned markets in North America (combining the US, Canadian and Puerto Rican businesses) and has established new operational areas in Europe to maximize their potential and opportunities for growth.

GSK Corporate Executive Team (effective May 22nd 2008):
- Andrew Witty, Chief Executive Officer (and member of Board of Directors)
- Julian Heslop, Chief Financial Officer (and member of Board of Directors)
- Moncef Slaoui, Chairman, Research & Development (and member of Board of Directors)
- Chris Viehbacher, President, North American Pharmaceuticals (and member of Board of Directors)
- Simon Bicknell, SVP, Company Secretary & Compliance Officer
- John Clarke, President, Consumer Healthcare
- Marc Dunoyer, President, Asia Pacific
- Eddie Gray, President, Pharmaceuticals Europe
- Abbas Hussain, President, Emerging Markets. He will join GSK from Eli Lilly and Company, June 2
- Duncan Learmouth, SVP, Corporate Communications & Global Community Partnerships
- Bill Louv, Chief Information Officer
- Dan Phelan, Chief of Staff
- David Pulman, President, Global Manufacturing & Supply
- David Redfern, Chief Strategy Officer
- Jean Stephenne, President and General Manager, Biologicals
- Claire Thomas, SVP, Human Resources
- SVP & General Counsel (currently vacant)

Post to: